Minimally Invasive Myxoma Resection: A Single-Center 5 Years’ Experience

Abstract

Background: There is an increasing demand for minimally invasive myxoma resection. This study aimed to investigate the safety and feasibility of minimally invasive myxoma resection. Methods: In this retrospective study, we collected information from 95 patients who underwent myxoma resection between January 2016 and December 2020. Based on the operative approach, the patients were divided into the minimally invasive myxoma resection (Mini-MR) group (N = 30) and the sternotomy myxoma resection (SMR) group (N = 65). Intraoperative and postoperative data were compared between the two groups. Results: The postoperative ventilator-assisted time, CSICU time, and postoperative hospital stay were shorter in the Mini-MR group than in the SMR (13.05 ± 4.98 vs. 17.07 ± 9.52 h; 1.73 ± 0.29 vs. 2.27 ± 1.53 d; 6.20 ± 1.50 vs. 9.48 ± 3.37 d, respectively), and the difference was statistically significant (P < 0.05). Mini-MR had lower postoperative drainage and blood transfusion rate in the first 24 h compared with SMR (38.93 ± 69.62 vs. 178.25 ± 153.06 ml; 26.6% vs. 63.1%), and the differences were statistically significant (P < 0.05). Conclusion: Mini-MR has the advantages of less CSICU stay time, less ventilator time, less postoperative drainage in the first 24h, less blood transfusion, fewer postoperative hospital stays, and faster recovery. Mini-MR is a safe and feasible surgical procedure for myxoma resection.

A comparison of total thoracoscopic versus robotic approach for cardiac myxoma resection: a single-center retrospective study

“…Since the first successful robotic cardiac myxoma resection performed by Murphy et al in 2005 [14], the procedure has been demonstrated as a safe and feasible method with rapid recovery, cosmetic superiority, and improved postoperative quality of life when compared to the conventional sternotomy approach [4,5,13,[15][16][17][18]. This study aims to explore the differences in clinical outcomes between robotic and thoracoscopic myxoma resection, which are not well documented in previous literature.…”

“…Massive allogenic blood transfusion is an independent risk factor for nosocomial pneumonia following cardiac surgeries and plays an important role in postoperative kidney injury [16]. Wei S et al [8] concluded that thoracoscopic surgeries have a lower transfusion rate than robotic surgeries (52.2% vs. 64.5%) [8].…”